Irving, Texas (RBC Life Sciences: OTCBB: RBCL) — A university clinical trial has shown that athletes dramatically increased their hydration values during intense exercise after consuming RBC Life Sciences' Microhydrin®—the nutrition industry's most uniquely formulated super antioxidant.
Exercise physiologists say that hydration is a critical aspect in health and sports competition. Athletes are encouraged to compete while well hydrated to maximize hormonal, mechanical and metabolic benefits.
Results of the trial conducted by the University of Oklahoma Department of Health and Exercise Science were presented in October at the American College of Sports Medicine.
As part of the trial, 15 cyclists participated in an exhaustive uphill bicycle climb in the laboratory. The cyclists consumed four Microhydrin capsules daily for one week prior to the trial. Thirty minutes before the climb, participants consumed three of the super antioxidant capsules with 16 ounces of water. After finishing the trial, the cyclists consumed one Microhydrin capsule with eight ounces of water.
The athletes' total body water and intracellular water "increased at a significantly greater rate" upon consuming the Microhydrin super antioxidant than when consuming the same amount of water alone, according to the study.
"We have numerous testimonies over the years—from weekend warriors to master marathon runner Andrey Kuznetsov—that Microhydrin plays a critical role in their exercise and competition regimens," said RBC Life Sciences founder and CEO, Clinton Howard. "Based on the significant increase in intracellular water as measured by this study, it's evident that Microhydrin has metabolically important functions at the cellular level."
Numerous clinical trials and studies over the last 10 years indicate that Microhydrin has myriad benefits, including increasing hydration, lowering lactic acid levels in blood during strenuous exercise and protecting against oxidative stress.*
Microhydrin's superior hydrating and antioxidant benefits are derived from the synergy among the ingredients in its unique formulation, which includes naturally occurring food-grade silica, potassium carbonate, magnesium sulfate and fatty acids. While a previous study had shown that Microhydrin enhanced hydration during daily activity, this new study indicates it also increases hydration during exhaustive exercise.
In 1991, Canadian physician Denis Brown tried to climb 28,750-foot Mt. Everest without supplemental oxygen. In 1994, he was able to reach 26,000 feet. Five years later, at age 47, Brown added Microhydrin to his regimen, hoping to reduce the build-up of free radicals and lactic acid. He succeeded in reaching the South Summit peak without supplemental oxygen.
Marathon runner Andrey Kuznetsov ran the Brazil Marathon in January 1997, at age 39, in 2 hr., 17 min. and 52 sec. In 1999, after adding Microhydrin to his daily regimen, he won the Masters Division of the Boston Marathon in 2 hr., 14 min. and 20 sec., despite a pervasive heat that knocked many runners out of the race. After the race in the recovery room, Kuznetsov was standing, appearing relaxed, while others were collapsed on cots and being treated for hyperthermia and vomiting, said the runner's nutritional advisor, Leonard Smith, M.D.
* These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at http://www.rbclifesciences.com/.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
Contacts:
Alan Van Zelfden
RBC Life Sciences
972-893-4050
Ann Billings
RBC Life Sciences
search blogs
share it
blog it
